Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Capital Employed (2016 - 2025)

Integra Lifesciences Holdings' Return on Capital Employed history spans 14 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 16.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, down 16.0%, while the annual FY2025 figure was 0.15%, 16.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.16% at Integra Lifesciences Holdings, down from 0.15% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.07% in Q4 2022 and bottomed at 0.17% in Q2 2025.
  • The 4-year median for Return on Capital Employed is 0.02% (2024), against an average of 0.01%.
  • The largest annual shift saw Return on Capital Employed changed 0bps in 2023 before it fell -19bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.07% in 2022, then plummeted by -52bps to 0.03% in 2023, then tumbled by -72bps to 0.01% in 2024, then tumbled by -1815bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for IART's Return on Capital Employed are 0.16% (Q4 2025), 0.15% (Q3 2025), and 0.17% (Q2 2025).